Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: Results of 4,062 intrauterine insemination.

Slides:



Advertisements
Similar presentations
What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.
Advertisements

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Male infertility: a biomarker of individual and familial cancer risk
Patient-specific predictions of outcome after gonadotropin ovulation induction/intrauterine insemination  Randi H. Goldman, M.D., Maria Batsis, M.D.,
Age at menarche: a predictor of diminished ovarian function?
Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada  Natalie Dayan, M.D., Andrea Lanes, M.Sc.,
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis.
A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates  Paul B. Marshburn, M.D., Mark Alanis,
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
Isiah D. Harris, M. D. , Johanne Python, M. D. , Lauren Roth, M. D
Conservative management of cervical ectopic pregnancy
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Ahmad Majzoub, M. D. , Nicholas N. Tadros, M. D. , A
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option?  Marine Quinquin,
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort.
Predictive value of the hemizona assay for pregnancy outcome in patients undergoing controlled ovarian hyperstimulation with intrauterine insemination 
Marcus W. Jurema, M. D. , Andrea D. Vieira, M. D
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk  Molly M. Quinn, M.D., Chia-Ning Kao,
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation  Maher A. Abdallah, M.D.,
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Male infertility: a biomarker of individual and familial cancer risk
Ovulation induction in women with polycystic ovary syndrome
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low.
Richard P. Dickey, M. D. , Ph. D. , Peter Y. Lu, M. D. , Belinda M
Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D
Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or.
Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography 
Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R
In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular.
Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D. 
Effectiveness of highly purified human menopausal gonadotropin vs
S. Samuel Kim, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Spontaneous pregnancy and birth of a normal female from a woman with Turner syndrome and elevated gonadotropins  Sarantis Livadas, M.D., Paraskevi Xekouki,
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination  Deirdre A.
Fertility and Sterility
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Defining the proliferative phase endometrial defect
In vitro sildenafil citrate use as a sperm motility stimulant
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
Soluble HLA-G in the peritoneal fluid of women with endometriosis
What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.
Brooks A. Keel, Ph.D., H.C.L.D.(A.B.B.)  Fertility and Sterility 
Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous?  John M. Norian, M.D., Eric D. Levens,
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
Contact among families who share the same sperm donor
Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility  William E Roudebush, Ph.D.,
The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women  Beth A. Malizia, M.D., Laura.
Presentation transcript:

Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: Results of 4,062 intrauterine insemination cycles  Richard P. Dickey, M.D., Ph.D., Steven N. Taylor, M.D., Peter Y. Lu, M.D., Belinda M. Sartor, M.D., Phillip H. Rye, M.D., Roman Pyrzak, Ph.D.  Fertility and Sterility  Volume 83, Issue 3, Pages 671-683 (March 2005) DOI: 10.1016/j.fertnstert.2004.10.030 Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Cumulative pregnancy rate. (A) Diagnosis. Male, Cervical, and Unexplained = normal cycles without endometriosis or tubal factor. Ovulatory Dysfunction = anovulatory, polycystic ovaries, or luteal insufficiency. Endometriosis = without tubal involvement. Tubal Factor = endometriosis with tubal involvement and tubal adhesions or unilateral tubal obstruction. Patients aged ≥38 years and cycles with total initial motile sperm count of <5 million or motility of <30% were excluded. (B) Age. Patients with endometriosis, tubal factor, and cycles with total initial motile sperm count of <5 million or motility of <30% were excluded. (C) Sperm characteristics. Donor = cryopreserved sperm with ≥30 million motile count. WHO Standard = ≥40 million total count, ≥50% progressive motility, 30% normal forms. IUI Threshold = less than WHO Standard but ≥5 million total motile sperm and ≥30% initial motility. <IUI Threshold = initial motile sperm count of <5 million or motility <30%. Patients aged ≥38 years and patients with tubal factor were excluded. (D) Follicle count. Patients aged ≥38 years, with tubal factor, and cycles with total initial motile sperm count of <5 million or motility of <30%, were excluded. Fertility and Sterility 2005 83, 671-683DOI: (10.1016/j.fertnstert.2004.10.030) Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Cumulative pregnancy rate. (A) Diagnosis. Male, Cervical, and Unexplained = normal cycles without endometriosis or tubal factor. Ovulatory Dysfunction = anovulatory, polycystic ovaries, or luteal insufficiency. Endometriosis = without tubal involvement. Tubal Factor = endometriosis with tubal involvement and tubal adhesions or unilateral tubal obstruction. Patients aged ≥38 years and cycles with total initial motile sperm count of <5 million or motility of <30% were excluded. (B) Age. Patients with endometriosis, tubal factor, and cycles with total initial motile sperm count of <5 million or motility of <30% were excluded. (C) Sperm characteristics. Donor = cryopreserved sperm with ≥30 million motile count. WHO Standard = ≥40 million total count, ≥50% progressive motility, 30% normal forms. IUI Threshold = less than WHO Standard but ≥5 million total motile sperm and ≥30% initial motility. <IUI Threshold = initial motile sperm count of <5 million or motility <30%. Patients aged ≥38 years and patients with tubal factor were excluded. (D) Follicle count. Patients aged ≥38 years, with tubal factor, and cycles with total initial motile sperm count of <5 million or motility of <30%, were excluded. Fertility and Sterility 2005 83, 671-683DOI: (10.1016/j.fertnstert.2004.10.030) Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions